Yes, I still have some shares left from a very long position I kept because of the Fabry drug and now I like the DNase candidate too.
Thanks for the detailed response. Very helpful, as always. I'm at least putting PLX on my watchlist as I could use a small-cap name in the biosimilar/biobetter space. Just don't know if I'll ever be in position to take a position given some other priorities. But, I do agree with jq's prior post that PLX and MNTA would be the names to consider here in this space.